A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease

Szilagyi, D. Emerick; Elliott, Joseph P.; Smith, Roger; Reddy, Daniel J.; McPharlin, Michalene

doi:10.1016/0741-5214(86)90104-7

Cited by 290 publications

(30 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Expanded polytetrafluoroethylene (ePTFE) and polyethylene terephthalate (PET) artificial blood vessels have been applied clinically for larger vessels replacement. However, serious problems such as intimal hyperplasia and embolism restrict their application in small vessels transplantation . The current standard for bypass surgery is to use autologous vessels such as internal mammary arteries or saphenous veins.…”

Section: Introductionmentioning

confidence: 99%

Comparison of two types of bioreactors for synthesis of bacterial nanocellulose tubes as potential medical prostheses including artificial blood vessels

Tang

Bao

et al. 2016

J of Chemical Tech & Biotech

View full text Add to dashboard Cite

BACKGROUND Bacterial nanocellulose (BNC) has prospects for use in applications of artificial blood vessels, esophagus and urethra. Several bioreactors have been utilized for synthesis of BNC tubes, however, little is known about differences in biosynthesis processes and tube properties. The current work for the first time compared two types of bioreactors, double‐silicone‐tube (D‐BNC) and single‐silicone‐tube (S‐BNC) bioreactors, to evaluate differences in preparation and properties of BNC tubes using fructose or glucose of 50 g L−1 and 100 g L−1, respectively. RESULTS The two bioreactors showed different biosynthesis processes of BNC tube production. The D‐BNC bioreactor provided higher yields and better mechanical performance of tubes because of the greater oxygen supply. Higher fructose concentration resulted in increased production of D‐BNC, but sugar types and concentrations had little effect on S‐BNC yields. Fructose granted stronger mechanical properties, but lower water permeability. Both types of tubes prepared with 100 g L−1 fructose were composed of porous nano‐fibrillar networks but showed different cross‐sectional morphologies and fiber distributions. CONCLUSION This study revealed the biosynthesis processes of BNC tubes in two bioreactors and their correlation with properties. The results suggest how to regulate BNC tubes with particular structures and properties for biomedical prostheses including artificial blood vessels. © 2016 Society of Chemical Industry

show abstract

Section: Introductionmentioning

confidence: 99%

Comparison of two types of bioreactors for synthesis of bacterial nanocellulose tubes as potential medical prostheses including artificial blood vessels

Tang

Bao

et al. 2016

J of Chemical Tech & Biotech

View full text Add to dashboard Cite

show abstract

“…Aortoiliac occlusive disease has historically been managed with ABF bypass because of its durability, with primary patency rates at 5 and 10 years ranging between 85% to 90% and 75% to 85%. 12,14 -16 However, overall morbidity rates range from an alarming 17% to 32%. 17,18 Graft infection, acute graft thrombosis, aortocaval, and aortoenteric fistulas can all be potential disastrous complications requiring extensive reintervention and graft excision.…”

Section: Discussionmentioning

confidence: 99%

Minimally Invasive Aortobiilliofemoral Endarterectomy for Aortoiliac Occlusive Disease Is a Compelling Alternative to Bypass

Theriot

Feldman

Korayem

et al. 2018

Vasc Endovascular Surg

View full text Add to dashboard Cite

Introduction: Aortobifemoral bypass is a time-honored, durable surgery allowing restoration of lower extremity blood. However, the potential for significant complications exists, impacting mortality, morbidity, and quality of life. Minimally invasive aortobiiliofemoral endarterectomy offers an alternative to prosthetic bypass and its associated complications. Here, we present a case series using remote endarterectomy for aortoiliac occlusive disease. Methods: Nine patients with aortoiliac occlusive disease were treated at a single institution, by a single surgeon, with direct and remote endarterectomy combination. Standard femoral access approach was used. A limited longitudinal distal aorta arteriotomy into the right common iliac artery to the hypogastric bifurcation was made. Then, an open thromboendarterectomy was performed. Circumferential common femoral endarterectomies were performed bilaterally and the plaque transected, allowing manually controlled Vollmar ring passage proximally to the iliac bifurcation on the right and the aortic bifurcation on the left. Aortoiliac arteriotomy was closed, followed by the femoral arteriotomies. Morbidity, secondary interventions, recurrent stenosis (adjacent segment velocity ratios 2), anklebrachial index (ABI), and patency rates were tracked postoperatively for 6 years. Kaplan-Meier life-table analysis was used to determine patency rates per the criteria of SVS and ISCS. Results: The average age was 59.1 years (54-87 years), and 88% were male. Comorbidities included hypertension (75%), former/current smokers (100%), and prior PAD surgical intervention (38%). Revascularization of 100% was achieved, with average ABI improving from 0.42 preoperatively to 0.92 postoperatively (0.91 at 8-month follow-up). Six-year patency rate was 100% without reintervention. Incidence of myocardial infarction, stroke, death, amputation, intestinal ischemia, sexual dysfunction, and aneurysmal degeneration was zero after 6 years of follow-up. Conclusion: Minimally invasive aortobiiliofemoral endarterectomy is a viable alternative to aortobifemoral bypass for the treatment of aortoiliac occlusive disease, allowing reestablishment of normal anatomic anatomy while avoiding the use of prosthetic material. Patency rates in this series was 100% at 6 years, with minimal postoperative complications or morbidity.

show abstract

“…17 Aortobifemoral bypass has a 3% to 8% mortality and 10% morbidity with complications such as graft failure (3%) and graft infection (1%). 18,19 These high complication rates have supported the use of the “kissing stents” technique for AIOD as a safer and effective alternative, even though midterm primary patency ranges from 84% to 92%. 20–22 Moreover, Danczyk et al 23 demonstrated that failed endovascular therapy for AIOD will not result in a worse outcome if secondary open surgery is required.…”

Section: Discussionmentioning

confidence: 99%

Results of AFX Unibody Stent-Graft Implantation in Patients With TASC D Aortoiliac Lesions and Coexistent Abdominal Aortic Aneurysms

et al. 2017

View full text Add to dashboard Cite

show abstract

A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease

Cited by 290 publications

References 1 publication

Comparison of two types of bioreactors for synthesis of bacterial nanocellulose tubes as potential medical prostheses including artificial blood vessels

Comparison of two types of bioreactors for synthesis of bacterial nanocellulose tubes as potential medical prostheses including artificial blood vessels

Minimally Invasive Aortobiilliofemoral Endarterectomy for Aortoiliac Occlusive Disease Is a Compelling Alternative to Bypass

Results of AFX Unibody Stent-Graft Implantation in Patients With TASC D Aortoiliac Lesions and Coexistent Abdominal Aortic Aneurysms

Contact Info

Product

Resources

About